vs
Healthpeak Properties（DOC）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Rollins, Inc.的季度营收约是Healthpeak Properties的1.3倍（$906.4M vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 11.9%，领先61.3%），Rollins, Inc.同比增速更快（10.2% vs 3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $111.2M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 0.8%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
DOC vs ROL — 直观对比
营收规模更大
ROL
是对方的1.3倍
$719.4M
营收增速更快
ROL
高出7.1%
3.1%
净利率更高
DOC
高出61.3%
11.9%
自由现金流更多
DOC
多$245.8M
$111.2M
两年增速更快
DOC
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $906.4M |
| 净利润 | $114.0M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | 17.4% | 16.1% |
| 净利率 | 73.2% | 11.9% |
| 营收同比 | 3.1% | 10.2% |
| 净利润同比 | 2406.4% | 2.5% |
| 每股收益（稀释后） | $0.16 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $719.4M | $912.9M | ||
| Q3 25 | $705.9M | $1.0B | ||
| Q2 25 | $694.3M | $999.5M | ||
| Q1 25 | $702.9M | $822.5M | ||
| Q4 24 | $698.0M | $832.2M | ||
| Q3 24 | $700.4M | $916.3M | ||
| Q2 24 | $695.5M | $891.9M |
净利润DOCROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $114.0M | $116.4M | ||
| Q3 25 | $-117.1M | $163.5M | ||
| Q2 25 | $31.7M | $141.5M | ||
| Q1 25 | $42.8M | $105.2M | ||
| Q4 24 | $4.5M | $105.7M | ||
| Q3 24 | $85.9M | $136.9M | ||
| Q2 24 | $146.0M | $129.4M |
毛利率DOCROL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — |
营业利润率DOCROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 17.4% | 17.5% | ||
| Q3 25 | 9.2% | 21.9% | ||
| Q2 25 | 5.7% | 19.8% | ||
| Q1 25 | 7.7% | 17.3% | ||
| Q4 24 | -2.2% | 18.1% | ||
| Q3 24 | 14.1% | 20.9% | ||
| Q2 24 | 22.3% | 20.4% |
净利率DOCROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 73.2% | 12.8% | ||
| Q3 25 | -16.6% | 15.9% | ||
| Q2 25 | 4.6% | 14.2% | ||
| Q1 25 | 6.1% | 12.8% | ||
| Q4 24 | 0.7% | 12.7% | ||
| Q3 24 | 12.3% | 14.9% | ||
| Q2 24 | 21.0% | 14.5% |
每股收益（稀释后）DOCROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $0.16 | $0.24 | ||
| Q3 25 | $-0.17 | $0.34 | ||
| Q2 25 | $0.05 | $0.29 | ||
| Q1 25 | $0.06 | $0.22 | ||
| Q4 24 | $0.02 | $0.22 | ||
| Q3 24 | $0.12 | $0.28 | ||
| Q2 24 | $0.21 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $116.5M |
| 总债务越低越好 | $9.8B | $650.6M |
| 股东权益账面价值 | $7.5B | $1.4B |
| 总资产 | $20.3B | $3.2B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资DOCROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $467.5M | $100.0M | ||
| Q3 25 | $91.0M | $127.4M | ||
| Q2 25 | $89.4M | $123.0M | ||
| Q1 25 | $70.6M | $201.2M | ||
| Q4 24 | $119.8M | $89.6M | ||
| Q3 24 | $180.4M | $95.3M | ||
| Q2 24 | $106.9M | $106.7M |
总债务DOCROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $9.8B | $486.1M | ||
| Q3 25 | $9.1B | $485.7M | ||
| Q2 25 | $9.0B | $485.3M | ||
| Q1 25 | $8.9B | $485.5M | ||
| Q4 24 | $8.7B | $395.3M | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — |
股东权益DOCROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $7.5B | $1.4B | ||
| Q3 25 | $7.6B | $1.5B | ||
| Q2 25 | $7.9B | $1.4B | ||
| Q1 25 | $8.2B | $1.4B | ||
| Q4 24 | $8.4B | $1.3B | ||
| Q3 24 | $8.6B | $1.3B | ||
| Q2 24 | $8.8B | $1.2B |
总资产DOCROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $20.3B | $3.1B | ||
| Q3 25 | $19.6B | $3.2B | ||
| Q2 25 | $19.8B | $3.2B | ||
| Q1 25 | $19.8B | $2.9B | ||
| Q4 24 | $19.9B | $2.8B | ||
| Q3 24 | $20.0B | $2.8B | ||
| Q2 24 | $20.2B | $2.8B |
负债/权益比DOCROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 1.31× | 0.35× | ||
| Q3 25 | 1.20× | 0.32× | ||
| Q2 25 | 1.14× | 0.34× | ||
| Q1 25 | 1.08× | 0.36× | ||
| Q4 24 | 1.04× | 0.30× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $111.2M |
| 自由现金流率自由现金流/营收 | 49.6% | 12.3% |
| 资本支出强度资本支出/营收 | 124.4% | 0.8% |
| 现金转化率经营现金流/净利润 | 10.99× | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势，按日历期对齐
经营现金流DOCROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $1.3B | $164.7M | ||
| Q3 25 | $315.0M | $191.3M | ||
| Q2 25 | $363.5M | $175.1M | ||
| Q1 25 | $279.4M | $146.9M | ||
| Q4 24 | $1.1B | $188.2M | ||
| Q3 24 | $318.2M | $146.9M | ||
| Q2 24 | $316.2M | $145.1M |
自由现金流DOCROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $357.0M | $159.0M | ||
| Q3 25 | — | $182.8M | ||
| Q2 25 | — | $168.0M | ||
| Q1 25 | — | $140.1M | ||
| Q4 24 | $333.7M | $184.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $136.4M |
自由现金流率DOCROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 49.6% | 17.4% | ||
| Q3 25 | — | 17.8% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | 47.8% | 22.1% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 15.3% |
资本支出强度DOCROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 124.4% | 0.6% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | 105.6% | 0.5% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.0% |
现金转化率DOCROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 10.99× | 1.41× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | 11.48× | 1.24× | ||
| Q1 25 | 6.52× | 1.40× | ||
| Q4 24 | 235.43× | 1.78× | ||
| Q3 24 | 3.71× | 1.07× | ||
| Q2 24 | 2.17× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
